Challenges facing the development and use of protein chips to analyze the phosphoproteome

Expert Review of Proteomics

Volumn 2, Issue 4, 2005, Pages 487-497

  Beernink, Hans T H ^b   Nock, Steffen ^a  

^a Absalus Inc   (United States)

^b Immunology R and D   (United States)

Author keywords

Antibody; Antibody fragment; Phage display; Phosphoprotein; Phosphorylation specific antibody; Protein array; Protein chip; Proteomics

Indexed keywords

PHOSPHOPROTEIN; PROTEOME;

ANTIBODY PRODUCTION; CONJUGATION; IMMUNIZATION; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW;

ANIMALS; ANTIBODIES; HUMANS; IMMUNOASSAY; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; PROTEOME;

EID: 23744444911     PISSN: 14789450     EISSN: None     Source Type: Journal    
DOI: 10.1586/14789450.2.4.487     Document Type: Review

References (45)

1. Johnson SA, Hunter T. Kinomics: methods for deciphering the kinome. Nature Methods 2(1), 17-25 (2005).
2. Salih E. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches. Mass Spectrom. Rev. 10 (2004).
3. Hunter T. Signaling - 2000 and beyond. Cell 100(1), 113-27 (2000).
4. Fung E (Ed.) Protein Arrays: Methods and Protocols. 278, Humana Press, CA, USA (2003).
5. Wilson DS, Nock S. Recent developments in protein microarray technology. Angew Chem. Int. Ed. Engl. 42(5), 494-500 (2003).
6. Witte KL, Nock S. Recent applications of protein arrays in target identification and disease monitoring. Drug Discov. Today 1(1), 35-40 (2004).
7. Pawlak M, Schick E, Bopp MA, Schneider MJ, Oroszlan P, Ehrat M. Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics 2(4), 383-393 (2002).
8. Senger DR, Perruzzi CA. Secreted phosphoprotein markers for neoplastic transformation of human epithelial and fibroblastic cells. Cancer Res. 45(11), 5818-5823 (1985).
9. Bodovitz S, Joos T, Bachmann J. Protein biochips: the calm before the storm. Drug Discov. Today 10(4), 283-287 (2005).
10. Phelan ML, Nock S. Generation of bioreagents for protein chips. Proteomics 3(11), 2123-2134 (2003). Comprehensive description of the issue of generating bioreagents.
11. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517), 495-497 (1975).
12. Spieker-Polet H, Sethupathi P, Yam P, Knight KL. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. Proc. Natl Acad. Sci. USA 92(20), 9348-9352 (1995).
13. Gembitsky DS, Lawlor K, Jacovina A, Yaneva M, Tempst P. A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol. Cell. Proteomics 3(11), 1102-1118 (2004).
14. Blaydes JP, Bojtesek B, Bloomberg GB, Hupp TR. The development and use of phospho-specific antibodies to study protein phosphorylation. Methods Mol. Biol. 99, 177-189 (2000).
15. Czernik AJ, Girault JA, Nairn AC et al. Production of phosphorylation state-specific antibodies. Methods Enzymol. 201, 264-283 (1991). Detailed description of making phosphospecific antibodies.
16. Harlow E, Land D. Antibodies: a Laboratory Manual. Cold Spring Habor, NY, USA (1988).
17. Borrebaeck CA, Ekstrom S, Hager AC et al. Protein chips based on recombinant antibody fragments: a highly sensitive approach as detected by mass spectrometry. Biotechniques 30(5), 1126-1132 (2001).
18. Steinhauer C, Wingren C, Hager AC, Borrebaeck CA. Single framework recombinant antibody fragments designed for protein chip applications. Biotechniques 12(Suppl.), 38-45 (2002).
19. Peluso P, Wilson DS, Do D et al. Optimizing antibody immobilization strategies for the construction of protein microarrays. Anal. Biochem. 312(2), 113-124 (2003). Detailed analysis of the impact of antibody orientation on the performance of chips.
20. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Ann. Rev. Immunol. 12, 433-455 (1994). Very good review on antibodies made by phage display.
21. Ling MM. Large antibody display libraries for isolation of high-affinity antibodies. Comb. Chem. High Throughput Screen. 6(5), 421-432 (2003).
22. Amstutz P, Forrer P, Zahnd C, Pluckthun A. In vitro display technologies: novel developments and applications. Curr. Opin. Biotechnol. 12(4), 400-405 (2001).
23. Conway T, Schoolnik GK. Microarray expression profiling: capturing a genome-wide portrait of the transcriptome. Mol. Microbiol. 47(4), 879-889 (2003).
24. Eisen MB, Brown PO. DNA arrays for analysis of gene expression. Methods Enzymol. 303, 179-205 (1999).
25. Velculescu VE, Madden SL, Zhang L et al. Analysis of human transcriptomes. Nature Genet. 23(4), 387-388 (1999).
26. van de Vijver MJ, He YD, van't Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347(25), 1999-2009 (2002).
27. Chan SM, Ermann J, Su L, Fathman CG, Utz PJ. Protein microarrays for multiplex analysis of signal transduction pathways. Nature Med. 10(12), 1390-1396 (2004).
28. Paweletz CP, Charboneau L, Bichsel VE et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20(16), 1981-1989 (2001).
29. Bobrow MN, Litt GJ, Shaughnessy KJ, Mayer PC, Conlon J. The use of catalyzed reporter deposition as a means of signal amplification in a variety of formats. J. Immunol. Methods 150(1-2), 145-149 (1992).
30. Charboneau L, Scott H, Chen T et al. Utility of reverse phase protein arrays: applications to signaling pathways and human body arrays. Brief Funct. Genomic Proteomic 1(3), 305-315 (2002).
31. Wulfkuhle JD, Aquino JA, Calvert VS et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3(11), 2085-2090 (2003).
32. Nishizuka S, Charboneau L, Young L et al. Proteomic profiling of the NCI-60 cencer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl Acad. Sci. USA 100(24), 14229-14234 (2003).
33. Herrmann PC, Gillespie JW, Charboneau L et al. Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 3(9), 1801-1810 (2003).
34. Nielsen UB, Cardone MH, Sinskey AJ, MacBeath G, Sorger PK. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc. Natl Acad. Sci. USA 100(16), 9330-9335 (2003).
35. Diks SH, Kok K, O'Toole T et al. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 279(47), 49206-49213 (2004).
36. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nature Rev. Mol. Cell. Biol. 4(6), 457-467 (2003).
37. Gavin AC, Bosche M, Krause R et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415(6868), 141-147 (2002).
38. Chen M, Cooper JA. Ser-3 is important for regulating Mos interaction with and stimulation of mitogen-activated protein kinase kinase. Mol. Cell. Biol. 15(9), 4727-4734 (1995).
39. Uetz P, Giot L, Cagney G et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403(6770), 623-627 (2000).
40. Zhou T, Aumais JO, Liu X, Yu-lee LY, Erikson RL. A role for Pik1 phosphorylation of NudC in cytokinesis. Dev. Cell 5(1), 127-138 (2003).
41. Irish JM, Hovland R, Krutzik PO et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118(2), 217-228 (2004). Very nice example of using multiparameter flow cytometry to measure phosphoprotein responses in cells in a multiplexed manner.
42. Manning G, Plowman GD, Hunter T, Sudarsanam S. Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 27(10), 514-520 (2002).
43. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 298(5600), 1912-1934 (2002). Very informative analysis of the human kinome.
44. Caenepeel S, Charydczak G, Sudarsanam S, Hunter T, Manning G. The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc. Natl Acad. Sci. USA 101(32), 11707-11712 (2004).
45. Diks SH, Peppelenbosch MP. Single cell proteomics for personalized medicine. Trends Mol. Medicine 10(12), 574-577 (2004).